Association Between<i>NRAS</i>and<i>BRAF</i>Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma

Nancy E. Thomas(University of North Carolina at Chapel Hill), Kathleen Conway(University of North Carolina at Chapel Hill), David W. Ollila(University of North Carolina at Chapel Hill), Anne Ε. Cust(The University of Sydney), Audrey Alexander(University of North Carolina at Chapel Hill), Klaus J. Busam(Memorial Sloan Kettering Cancer Center), Bruce K. Armstrong(University of New Mexico), Anne S. Reiner(Memorial Sloan Kettering Cancer Center), Lynn From(Women's College Hospital), Roberto Zanetti(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Pamela A. Groben(University of North Carolina at Chapel Hill), Anne Kricker(The University of Sydney), Richard P. Gallagher(BC Cancer Agency), Marianne Berwick(Memorial Sloan Kettering Cancer Center), Terence Dwyer(The University of Melbourne), Irene Orlow(Memorial Sloan Kettering Cancer Center), Stephen B. Gruber(City Of Hope National Medical Center), Hoda Anton‐Culver(University of California, Irvine), Colin B. Begg(Memorial Sloan Kettering Cancer Center), Eloise Parrish(University of North Carolina at Chapel Hill), Peter A. Kanetsky(Cancer Research And Biostatistics), Sharon N. Edmiston(University of North Carolina at Chapel Hill), Stefano Rosso(Piedmont Reference Center for Epidemiology and Cancer Prevention), Honglin Hao(University of North Carolina at Chapel Hill), Susan Paine(University of Auckland), Jill S. Frank(University of North Carolina at Chapel Hill), Lorraine D. Marrett(Cancer Care Ontario), Li Luo(University of New Mexico)
JAMA Oncology
April 9, 2015
Cited by 192


Related Papers